UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Antibiotic tolerance: targeting bacterial survival

Current opinion in microbiology, 2023-08, Vol.74, p.102328-102328, Article 102328

Boeck, Lucas

2023

Link zum Volltext

Verfügbarkeit prüfen

Acute effects of aerosolized iloprost in COPD related pulmonary hypertension - a randomized controlled crossover trial

PloS one, 2012-12, Vol.7 (12), p.e52248-e52248

2012

Link zum Volltext

Verfügbarkeit prüfen

Subjective and objective survival prediction in mechanically ventilated critically ill patients: a prospective cohort study

Critical care (London, England), 2023-04, Vol.27 (1), p.150-150, Article 150

2023

Link zum Volltext

Verfügbarkeit prüfen

Single-Breath Washout Tests to Assess Small Airway Disease in COPD

Chest, 2016-11, Vol.150 (5), p.1091-1100

2016

Link zum Volltext

Verfügbarkeit prüfen

Peripheral T cell cytokine responses for diagnosis of active tuberculosis

PloS one, 2012-04, Vol.7 (4), p.e35290-e35290

2012

Link zum Volltext

Verfügbarkeit prüfen

Adenovirus-Specific IgG Maturation as a Surrogate Marker in Acute Exacerbations of COPD

Chest, 2014-08, Vol.146 (2), p.339-347

2014

Link zum Volltext

Verfügbarkeit prüfen

The Sequential Organ Failure Assessment score and copeptin for predicting survival in ventilator-associated pneumonia

Journal of critical care, 2012-10, Vol.27 (5), p.523.e1-523.e9

2012

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic Stone Protein

Chest, 2011-10, Vol.140 (4), p.925-932

2011

Link zum Volltext

Verfügbarkeit prüfen

Intensified therapy with inhaled corticosteroids and long-acting b2-agonists at the onset of upper respiratory tract infection to prevent chronic obstructive pulmonary disease exacerbations a multicenter, randomized, double-blind, placebo-controlled trial

2018-05

Link zum Volltext

Verfügbarkeit prüfen

Mortality risk prediction in COPD by a prognostic biomarker panel

The European respiratory journal, 2014-12, Vol.44 (6), p.1557-1570

2014

Link zum Volltext

Verfügbarkeit prüfen

Does Dose Matter?/Reply

American journal of respiratory and critical care medicine, 2018-10, Vol.198 (8), p.1102-1105

2018

Link zum Volltext

Verfügbarkeit prüfen

Reply to Palmer et al.: Does Dose Matter?

American journal of respiratory and critical care medicine, 2018-10, Vol.198 (8), p.1103-1105

2018

Link zum Volltext

Verfügbarkeit prüfen

Intensified Therapy with Inhaled Corticosteroids and Long-Acting β 2 -Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations. A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

American journal of respiratory and critical care medicine, 2018-05, Vol.197 (9), p.1136-1146

2018

Link zum Volltext

Verfügbarkeit prüfen

Intensified Therapy with Inhaled Corticosteroids and Long-Acting β2-Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations: A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

American journal of respiratory and critical care medicine, 2018-05, Vol.197 (9), p.1136-1146

2018

Link zum Volltext

Verfügbarkeit prüfen

Pancreatic Stone Protein: A Marker of Organ Failure and Outcome in Ventilator-Associated Pneumonia

Chest, 2011-10, Vol.140 (4), p.925-932

2011

Link zum Volltext

Verfügbarkeit prüfen

Prognostic assessment in COPD without lung function: the B-AE-D indices

The European respiratory journal, 2016-06, Vol.47 (6), p.1635-1644

2016

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Measurement of Serum Vascular Endothelial Growth Factor in Patients with Chronic Obstructive Pulmonary Disease

Respiration, 2015-01, Vol.90 (2), p.97-104

2015

Link zum Volltext

Verfügbarkeit prüfen

Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease

Respiration, 2015-01, Vol.90 (5), p.357-368

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD

Respirology (Carlton, Vic.), 2016-07, Vol.21 (5), p.883-890

2016

Link zum Volltext

Verfügbarkeit prüfen

Mycobacterium abscessus pathogenesis identified by phenogenomic analyses

Nature microbiology, 2022-09, Vol.7 (9), p.1431

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD

Pulmonary pharmacology & therapeutics, 2018-02, Vol.48, p.111-116

2018

Link zum Volltext

Verfügbarkeit prüfen

Specific cytokine patterns of pulmonary tuberculosis in Central Africa

Clinical immunology (Orlando, Fla.), 2011-01, Vol.138 (1), p.50-59

2011

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

Nature communications, 2020-09, Vol.11 (1), p.4545-4545, Article 4545

2020

Link zum Volltext

Verfügbarkeit prüfen

Alterations in CD39/CD73 axis of T cells associated with COVID‐19 severity

Journal of cellular physiology, 2022-08, Vol.237 (8), p.3394-3407

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(34)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(21)
Life Sciences & Biomedicine
(21)
Female
(16)
Male
(16)
Aged
(15)
Middle Aged
(14)
Respiratory System
(10)
Prognosis
(9)
Adult
(7)
Chronic Obstructive Pulmonary Disease
(7)
Human Health Sciences
(7)
Sciences De La Santé Humaine
(7)
Cardiovascular & Respiratory Systems
(6)
Critical Care Medicine
(6)
General & Internal Medicine
(6)
Mortality
(6)
Systèmes Cardiovasculaire & Respiratoire
(6)
Animals
(5)
Biomarkers - Blood
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibiotic tolerance: targeting bacterial survival

Acute effects of aerosolized iloprost in COPD related pulmonary hypertension - a randomized controlled crossover trial

Subjective and objective survival prediction in mechanically ventilated critically ill patients: a prospective cohort study

Single-Breath Washout Tests to Assess Small Airway Disease in COPD

Exertional Hypoxemia in Stable COPD Is Common and Predicted by Circulating Proadrenomedullin

Peripheral T cell cytokine responses for diagnosis of active tuberculosis

Adenovirus-Specific IgG Maturation as a Surrogate Marker in Acute Exacerbations of COPD

The Sequential Organ Failure Assessment score and copeptin for predicting survival in ventilator-associated pneumonia

Pancreatic Stone Protein

Intensified therapy with inhaled corticosteroids and long-acting b2-agonists at the onset of upper respiratory tract infection to prevent chronic obstructive pulmonary disease exacerbations a multicenter, randomized, double-blind, placebo-controlled trial

Mortality risk prediction in COPD by a prognostic biomarker panel

Does Dose Matter?/Reply

Reply to Palmer et al.: Does Dose Matter?

Intensified Therapy with Inhaled Corticosteroids and Long-Acting β 2 -Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations. A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

Intensified Therapy with Inhaled Corticosteroids and Long-Acting β2-Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations: A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

Pancreatic Stone Protein: A Marker of Organ Failure and Outcome in Ventilator-Associated Pneumonia

Prognostic assessment in COPD without lung function: the B-AE-D indices

Longitudinal Measurement of Serum Vascular Endothelial Growth Factor in Patients with Chronic Obstructive Pulmonary Disease

Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease

Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD

Mycobacterium abscessus pathogenesis identified by phenogenomic analyses

Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD

Specific cytokine patterns of pulmonary tuberculosis in Central Africa

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

Alterations in CD39/CD73 axis of T cells associated with COVID‐19 severity

Suchergebnisse filtern